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Lemon verbena (vervain, LV) is used in traditional folk medicine as a remedy against asthma, 
spasms, cold, fever, pain of different genesis, insomnia, etc., but its effects have not been 
examined experimentally. We studied effects of an aqueous extract of leafs of this plant on 
the parameters of nociception-related tests, tail-flick, and writhing ones. The first aqueous 
extract of LV leafs was prepared and dried. Wistar rats were randomly divided into seven ex-
perimental groups, which received i.p. injections of saline (control), LV extract (10, 100, 500, 
and 1000 mg of dry substance per 1 kg of the body mass), morphine, and 1000 mg/kg of the 
LV extract + naloxone. Injections of 500 and 1000 mg/kg of the extract significantly increased 
the tail-flick latency, as compared to that in the control group (P < 0.001). The number of 
writhings per one hour decreased after injections of the extract (100-1000 mg/kg). The maxi-
mum analgesic effects of the extract were comparable with those of morphine (10 mg/kg). 
Naloxone completely abolished the effect of the LV extract in the tail-flick test and partly 
suppressed such action in the writhing test. Thus, our experiments demonstrated noticeable 
anti-nociceptive effects of the aqueous LV extract; possibilities for application of this extract 
or its derivatives in pain management should be examined.
Keywords: lemon verbena, aqueous extract, analgesic effects, tail-flick test, writhing 
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INTRODUCTION
Search for effective analgesic agents having minimum 
side effects is an important task in neuropharmacology 
and neurophysiology [1, 2]. At present, a number of 
means (mostly plant-derived) used in traditional 
folk medicine are subjected to intense research from 
this aspect. Such studies inevitably include accurate 
experimental testing of the respective capabilities 
of the respective remedies and tempts to elucidate 
biochemical and pharmacological mechanisms of the 
effects of active constituents of such means. 
Lemon verbena (LV, Aloysia citroiodora, Lippia 
citroiodora Kunth, or Verbena triphylla; there are 
some other synonyms) is a perennial shrub belonging 
to the family of Verbenaceae. It is native to South-
western America, brought to Europe by the Spanish 
and Portuguese in the 17th century and cultivated 
for its oil [3]. It has been traditionally used in folk 
medicine as a remedy in treatments of asthma, spasms, 
cold, fever, flatulence, colic, indigestion, insomnia, 
anxiety, and headache [4, 5]. Its constituents were 
demonstrated to exert antioxidant effects [6–8]. At the 
same time, the effects of remedies prepared from LV 
have not been studied experimentally until now. 
We tried to estimate quantitatively the effects of the 
aqueous extract of LV in extensively used nociception-
related tests, tail-flick and writhing ones, in adult male 
rats. 
METHODS
Preparation of the Extract. Dried LV leafs were 
bought from the Mehr Giahe Kosar Company 
(Medicinal Plants Company) in Iran-Shiraz. Leafs 
were chopped by an electrical grinder; 500 g of the 
material were soaked into 2.0 l of distilled water for 
12 h at room temperature. The extract was filtered 
through filter paper (Whatman, Cat No 1442 125), got 
dry in a hot air oven (50°C), and turned into powder. 
The obtained powder was stored in a refrigerator. For 
injections, the required amounts of dry extract powder 
were weighed and dissolved in normal saline.
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Experimental  Groups .  Male  Wis tar  ra t s 
(180-200 g) were bought from the Pasteur Institute of 
Iran, housed in groups of three in polypropylene cages 
with free access to water and food ad libitum, and kept 
in a room under controlled conditions (24 ± 1°C and a 
12/12 h light/dark cycle). 
The rats were randomly divided into seven 
experimental groups (n = 8 in each). Animals of the 
control group received i.p. normal saline (0.5 ml), 
those of four LV groups were i.p. injected with 10, 
100, 500, and 1000 mg/kg of the extract; the morphine 
group received 10 mg/kg morphine, and the 7th group 
was injected with naloxone (4 mg/kg) + LV extract 
(1000 mg/kg).
Evaluation of Anti-Nociceptive Activity. 
Tail-Flick Test. A standard technique of this test 
was used. The tail flick latency (TFL) was measured as 
the time interval between the beginning of application 
of radiant heat from an infrared stimulator (tail-flick 
apparatus) to the rat’s tail (5-8 cm from the tip) and 
the moment of tail withdrawal. The intensity of radiant 
heat was adjusted to establish the TFL value of 2-3 sec. 
The baseline latency was obtained using the mean of 
three similar consecutive measurements. To avoid tis-
sue damage, a cut-off time of 10 sec was set [9, 10].
The measurements were performed before and 
20 min after the treatment with normal saline (control 
group), extract (four experimental groups), or 
morphine. In the naloxone + LV extract group, the TFL 
was first measured; then naloxone and, 10 min later, 
the LV extract were injected i.p., and, finally, the TFL 
was measured again 20 min later. In all cases, means 
of three measurements were taken into consideration.
Writhing Test. Thirty minutes after the treatment 
with saline or LV extract, 1 ml of 1% acetic acid 
solution was injected i.p. into experimental rats. Then, 
the animals were placed immediately into a glass box, 
and the number of abdominal constrictions (writhings) 
was counted for 1 h. The rats with a decreased 
number of writhings were considered protected from 
nociception [11, 12].
Statistical Analysis. Numerical data in the groups 
were compared by one-way analysis of variance 
(ANOVA) followed by the Tukey post­hoc test. The 
results are expressed below as means ± s.e.m. and 
P < 0.05 was considered as significant in intergroup 
comparisons. 
RESULTS
Tail-Flick Test. There were no significant 
differences between the TFL values before LV or 
morphine injections among the experimental groups 
(F
(6,49)
 = 3.120, P > 0.05). However, the significant 
between-group differences in the TFL appeared after 
treatment (F
(6,49)
 = 62.412, P < 0.001). The respective 
index showed no significant differences after 
injections of the LV extract in the doses of 10 and 
100 mg/kg. The dose 500 mg/kg, however, induced 
highly significant prolongation of the TLF (P < 
< 0.001, as compared to the control). At the dose of 
1000 mg/kg, the TLF was about three times longer 
than that in the control (P < 0.001) and was nearly 
equal to that observed after injection of a “standard” 
opioid analgesic, morphine. Preliminary injection 
of the opioid receptor antagonist naloxone resulted 
in practically complete removal of the effect of 
1000 mg/kg of the LV extract (P > 0.05 in comparison 
with the control; Fig. 1). 
Writhing Test. Injections of 100 to 1000 mg/kg 
of the LV extract provided significant decreases 
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F i g. 1. Latencies, sec, of the tail-flick responses before (dashed 
columns) and 20 min after (filled columns) the treatment with 
normal saline (contr.), lemon verbena extract (LV; 10, 100, 500, 
and 1000 mg/kg), morphine (Mor., 10 mg/kg), and naloxone + 
+ LV extract (1000 mg/kg); n = 8 in each group; intragroup 
means ± s.e.m. values are shown. ***P < 0.001, as compared to the 
control.
Р и с. 1. Значення латентного періоду (с) реакцій відсмикування 
хвоста перед та через 20 хв після введення тестованих агентів 
(заштриховані та чорні стовпчики відповідно). 
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in the number of writhings within the test period 
(60 min; F
(6,49)
 = 34.361, P < 0.001). At the first of the 
mentioned doses, the writhing number corresponded 
to 42% of that in the control (saline) group 
(P < 0.001). Greater doses of the extract (500 and 
1000 mg/kg) provided nearly complete inhibition of 
writhing movements induced by visceral pain after 
acetic acid test injections (P < 0.001 in both cases). 
Injections of morphine provided nearly the same effect 
(P < 0.001). The smallest of the extract doses used 
(10 mg/kg) exerted no significant effect on the results 
of the writhing test (P > 0.05). Injections of naloxone 
made before introductions of 1000 mg/kg of the LV 
extract resulted in significant (P < 0.01) suppression of 
the analgesic effect of this extract, but this suppression 
was not complete; the number of writhings during the 
test period corresponded to 62% of the respective 
index in the control (Fig. 2). 
localized in the skin of the rat’s tail. Results of the 
writhing test reflect generalized motor reactions 
induced by transient visceral pain developing after 
stimulation of visceral chemonociceptors by the acetic 
acid solution. Both tail-flick and writhing tests are 
used to detect the actions of central and peripheral 
analgesics. It should be noted that results of the 
tail-slick test are more sensitive to centrally acting 
analgesics. 
The nociceptive effect in the above test is relatively 
short-lasting and is intensely influenced by agonists 
of µ-opioid receptors responsible for analgesia in 
acute pain models. Therefore, it is believed that 
agents effective in this test exert their influences 
predominantly through μ-opioid receptors [13, 14]. 
Our observations show that the analgesic effect of 
the aqueous LV extract is nearly fully prevented by 
pretreatment with the opioid antagonist naloxone; 
thus, in the tail-flick test this extract predominantly 
affects the opioid system. 
The situation is somewhat different in the writhing 
test. Intraperitoneal administration of acetic acid 
results in the release of prostaglandins (like PGE2 
and PGF2α) and sympathomimetic mediators; their 
levels are increased in the peritoneal fluid of the 
acetic acid-injected rat [15]. Abdominal constrictions 
produced after administration of acetic acid are related 
to sensitization of nociceptors to prostaglandins [16]. 
Thus, it is possible that the effect of the LV extracts 
is also based on inhibition of synthesis and/or release 
of prostaglandins. It was reported that the leaves of 
LV are rich in flavonoids and aldehydes (in particular, 
citral and citronellal) [4]. Flavonoids are well-known 
agents exerting anti-inflammatory and analgesic 
effects; furthermore, their effect on prostaglandins 
has been proved [17]. It seems probable that a part 
of the analgesic effect of the LV extract is related 
to a compound called verbascoside. The latter is 
a phenylpropanoid glycoside isolated from a few 
medicinal plants of different families, in particular, 
those of Verbenaceae including Lippia citriodora [18-
20]. In previous studies, noticeable anti-inflammatory 
and analgesic effects of verbascoside have been well-
documented [18]. It has also been reported that the 
analgesic effect of verbascoside is not prevented by 
pretreatment with the opioid antagonist naloxone; the 
effects of verbascoside do not require activation of the 
opioid system [18].
Therefore, administration of the aqueous LV 
extract exerts clearly pronounced dose-dependent 
analgesic effects in both tail-flick and writhing tests 
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F i g. 2. Effects of administration of normal saline, different doses of 
lemon verbena (LV) extract, morphine, and naloxone + LV extract 
on the number of acetic acid-induced writhings within a 60 min 
observation period. ***P < 0.001, **P < 0.01, as compared to the 
control. Other designations are similar to those in Fig. 1. 
Р и с. 2. Впливи введення фізіологічного розчину, водного 
екстракту листя лимонної вербени (ЛВ) у різних дозах, морфіну 
та налоксону + екстракт ЛВ на кількість «корчів» протягом 60 
хв спостереження. 
DISCUSSION
The results of our study indicated that the aqueous LV 
extract is capable of exerting rather intense and highly 
significant antinociceptive effects in both tail-flick 
and writhing tests. In the former test, acute pain results 
from activation of high-threshold thermonociceptors 
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in rats. A part of the analgesic effects of this extract 
is due to activation of the opioid system. It can be 
suggested that the extract of LV may be considered 
a complementary analgesic mean counteracting pain 
of different geneses. At the same time, it should be 
noted that significant analgesic effects were provided 
by rather high doses of the extract. Thus, it seems 
that further research directed toward isolation of most 
effective constituents of such extracts is expedient; 
this, probably, can help to obtain some effective LV-
based means usable in clinics. 
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АНАЛГЕТИЧНА ДІЯ ВОДНОГО ЕКСТРАКТУ 
ЛИМОННОЇ ВЕРБЕНИ У ЩУРІВ
1 Дослідницький центр із нейрофізіології при Хамадан-
ському медичному університеті (Іран).
Р е з ю м е
Лимонна вербена (ЛВ) використовується в традиційній народ-
ній медицині як засіб проти астми, спазмів, застуди, лихоман-
ки, болю різного походження, безсоння і т. п., проте її ефекти 
не досліджувались експериментально. Ми вивчали дію водного 
екстракту листя цієї рослини на параметри тестів, пов’язаних 
із ноцицепцією, – тесту відсмикування хвоста та тесту «кис-
лотних корчів». Готували перший водний екстракт із листя ЛВ 
та дегітратували його. Досліди були проведені на семи екс-
периментальних групах щурів лінії Вістар; тварини цих груп 
отримували внутрішньоочеревинні ін’єкції фізіологічного роз-
чину (контроль), ЛВ-екстракту в чотирьох дозах (10, 100, 500 
та 1000 мг сухої речовини на 1 кг маси тіла), морфіну та екс-
тракту ЛВ (1000 мг/кг) із попередньою ін’єкцією налоксону. 
Ін’єкції екстракту в дозах 500 та 1000 мг/кг призводили до 
істотного збільшення латентного періоду реакції відсмику-
вання хвоста порівняно з аналогічним показником у контролі 
(P < 0.001). Кількість «корчів» у відповідному тесті протягом 
1 год істотно зменшувалася після ін’єкцій екстракту в дозах 
від 100 до 1000 мг/кг. Максимальні аналгетичні ефекти були 
близькими до таких після ін’єкцій морфіну (10 мг/кг). Налок-
сон повністю усував ефекти екстракту ЛВ у тесті відсмику-
вання хвоста, але лише частково пригнічував відповідну дію 
в тесті «корчів». Отже, результати наших експериментів по-
казали, що водний екстракт листя ЛВ має відчутну антиноци-
цептивну дію; можливості застосування цього екстракту або 
його похідних у контролі болю мають бути досліджені в по-
дальшому. 
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